European Commission Purchases an Additional 80 Million COVID-19 Vaccine Doses

Moderna, Inc. announced that the European Commission had exercised its option to purchase an additional 80 million doses of mRNA-1273, Moderna’s COVID-19 vaccine candidate, bringing its confirmed order commitment to 160 million doses.

The first deliveries of the experimental mRNA-1273 vaccine to European countries from Modena’s dedicated European supply chain are expected to commence early in 2021 following the EMA's regulatory approval.

Stéphane Bancel, CEO of Moderna, said, “As we shift our focus now to prepare for the delivery of our vaccine candidate, pending a positive opinion from the EMA and other regulators, we remain committed to working with governments and partners globally to address this pandemic.”